Business Model – A blueprint that ensures success of businesses, aligns operations with business strategies, improves process communication, increases control and consistency, improves operational efficiencies, offers competitive advantages, and amplifies revenues

The high rate of healthcare-associated infections (HAIs) is a major challenge for hospitals and healthcare providers across the globe. Medical devices can be a major source of HAIs and the use of antimicrobial coatings on a wide range of medical devices is an important measure to curb the growing rate of HAIs.

Globally, a number of factors such as the increasing risk of HAIs, rising geriatric population, technological advancements, and availability of funding form various government bodies is expected to trigger the growth of the antimicrobial coatings market for medical devices. However, limitations of silver-ion coatings, presence of time- and resource-intensive processes for the development and approval of antimicrobial coatings, and unfavorable healthcare reforms in the U.S. are restraining the growth of this market.

Download the PDF Brochure for More Details@ http://bit.ly/2OfSFJP

The antimicrobial coatings market for medical devices is marked by the presence of well-established firms as well as smaller firms. Some of the prominent players in the global antimicrobial coatings market include BASF SE (Germany), AST Products, Inc. (U.S.), BioInteractions LTD (U.K.), Covalon Technologies LTD (Canada), Sciessent LLC (U.S.), Royal DSM (Netherlands), Specialty Coating Systems, Inc. (U.S.), The Dow Chemical Company (U.S.), Hydromer, Inc. (U.S.), and PPG Industries, Inc. (U.S.).

This report provides in-depth assessment of the business models of leading companies (Specialty Coatings Systems, Inc. (SCS), Royal DSM, Hydromer, Inc., PPG Industries, Inc., and BASF SE) operating in the antimicrobial coatings market for medical devices. Manufacturers, start-up firms/entrepreneurs, resellers/channel partners/distributors (citing backward integration), market research & business consulting firms, and venture capitalists/investment firms are some of the key stakeholders who are likely to benefit from the business models of market players.

The research findings cited in this report encapsulate activities associated with designing a business, purchasing raw materials, manufacturing of products, finding and reaching customers, transacting a sale, distributing a product, or delivering a service. Manufacturing capabilities, R&D capabilities, logistic capabilities, distributor/supplier/sales channel networks, marketing & promotional activities, key resources, value propositions, key growth strategies, customer orientation/customer relationship management, pre- & post-sales services, customer segments, offices & warehouses, cost structures, and revenue streams, among other factors are some of the key attributes that are discussed at length in this report.

You Can Also Talk to Our Research Experts for More Detailed Information@ http://bit.ly/2Q7axbI

A business model can be beneficial for the following stakeholders:

• Manufacturers
• Start-up Firms/Entrepreneurs
• Resellers/Channel Partners/Distributors (Citing backward integration)
• Market Research & Business Consulting Firms
• Venture Capitalists/Investment Firms